Colistin in combination with rifampin and imipenem for treating a blaVIM-1 metallo-beta-lactamase-producing Enterobacter cloacae disseminated infection in a liver transplant patient

Minerva Anestesiol. 2008 Jan-Feb;74(1-2):47-9. Epub 2007 Dec 3.

Abstract

A case of bla(VIM-1) producing E. cloacae disseminated infection in a patient submitted to orthotopic liver transplantation is described. Synergism between colistin, rifampin and imipenem was studied in vitro and this combination of three drugs was used to treat E. cloacae infection. The synergistic activity of this combination was demonstrated showing an increased activity of the serum bactericidal activity in comparison with the bactericidal activity of the serum taken during the previous therapy.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Colistin / administration & dosage*
  • Drug Synergism
  • Drug Therapy, Combination
  • Enterobacter cloacae* / enzymology
  • Enterobacteriaceae Infections / drug therapy*
  • Humans
  • Imipenem / administration & dosage*
  • Liver Transplantation / adverse effects*
  • Male
  • Middle Aged
  • Rifampin / administration & dosage*
  • beta-Lactamases / biosynthesis

Substances

  • Anti-Bacterial Agents
  • Imipenem
  • VIM-1 metallo-beta-lactamase
  • beta-Lactamases
  • Rifampin
  • Colistin